Dimensional Fund Advisors
TXMD icon

Dimensional Fund Advisors’s TherapeuticsMD TXMD Stock Holding History

Dimensional Fund Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.6K Buy
19,719
+9,013
+84% +$18.6K ﹤0.01% 3201
2026
Q1 		$21.6K Buy
+10,706
New +$24.1K ﹤0.01% 3204
2024
Q2 		– Sell
-10,154
Closed -$23.3K – 3411
2024
Q1 		$23.3K Hold
10,154
– – ﹤0.01% 3361
2023
Q4 		$22.8K Hold
10,154
– – ﹤0.01% 3383
2023
Q3 		$30.7K Buy
+10,154
New +$38.4K ﹤0.01% 3417

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dimensional Fund Advisors's TXMD Position: Q2 2026 in Review

Dimensional Fund Advisors increased its TherapeuticsMD (TXMD) stake by 84% in Q2 2026, buying an estimated $18.6K and bringing the position to 19,719 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3201.

Dimensional Fund Advisors first reported a position in TXMD in Q3 2023 and has held it in 5 quarters since. 44 funds tracked by Wall St. Rank hold TXMD as of Q2 2026.

  • Dimensional Fund Advisors held 19,719 shares of TherapeuticsMD worth $43.6K as of Q2 2026.
  • Dimensional Fund Advisors bought 9,013 TherapeuticsMD shares in Q2 2026, an estimated $18.6K.
  • TherapeuticsMD made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3201 holding.
  • Dimensional Fund Advisors first reported a position in TherapeuticsMD in Q3 2023 and has held it in 5 quarters since.
  • 44 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.